54
44
Growth Score
-17 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1527228
SpikImm develops monoclonal antibodies for viral infection prevention and treatment, including COVID-19.
About the Company
SpikImm is a biotechnology company focused on developing monoclonal antibodies for the prevention and treatment of severe viral infections. The company collaborates with Truffle Capital and the Institut Pasteur to advance its research and development efforts. SpikImm's primary product, SPK001, is an anti-SARS CoV-2 monoclonal antibody
candidate aimed at providing innovative treatments for COVID-19. The company also explores prophylactic treatments for viral infections in immunocompromised patients, leveraging its expertise in antibody development.
